Zobrazeno 1 - 10
of 105
pro vyhledávání: '"C.V. Damaraju"'
Autor:
C. Michael Gibson, Steven Steinhubl, Dhanunjaya Lakkireddy, Mintu P. Turakhia, Rod Passman, W. Schuyler Jones, T. Jared Bunch, Anne B. Curtis, Eric D. Peterson, Jeremy Ruskin, Leslie Saxon, Michael Tarino, Khaldoun G. Tarakji, Nassir Marrouche, Mithun Patel, Ante Harxhi, Simrati Kaul, Janeta Nikolovski, Stephanie Juan, Kevin Wildenhaus, C.V. Damaraju, John A. Spertus
Publikováno v:
American Heart Journal. 259:30-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b052c8a76c72aa332b01bb713241b939
https://doi.org/10.1016/j.ahj.2023.01.004
https://doi.org/10.1016/j.ahj.2023.01.004
Autor:
Ashish Sarraju, George Bakris, Christopher P. Cannon, David Cherney, C.V. Damaraju, Gemma A. Figtree, Jagadish Gogate, Tom Greene, Hiddo J.L. Heerspink, James L. Januzzi, Bruce Neal, Meg J. Jardine, Jaime Blais, Mikhail Kosiborod, Adeera Levin, Ildiko Lingvay, Matthew R. Weir, Vlado Perkovic, Kenneth W. Mahaffey
Publikováno v:
Journal of the American College of Cardiology, 80(18), 1721-1731. ELSEVIER SCIENCE INC
Background: People with type 2 diabetes mellitus (T2DM) have elevated cardiovascular (CV) risk, including for hospitalization for heart failure (HHF). Canagliflozin reduced CV and kidney events in patients with T2DM and high CV risk or nephropathy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de342bc05432e12b4a472cf89b3a2569
https://pubmed.ncbi.nlm.nih.gov/36302585
https://pubmed.ncbi.nlm.nih.gov/36302585
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 24(1)
Aims People with type 2 diabetes mellitus (T2DM) have a greater risk of cardiovascular disease and major adverse cardiovascular events (MACE), which become more common as kidney function declines. Canagliflozin reduced the risk of MACE (cardiovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d346b6dedc8c508fbca34f1e1824f29
https://pubmed.ncbi.nlm.nih.gov/34463423
https://pubmed.ncbi.nlm.nih.gov/34463423
Autor:
John Barnard, Theodore Wun, C.V. Damaraju, Alok A. Khorana, Ujjwala Vijapurkar, Kenneth Todd Moore, Peter Wildgoose, Keith R. McCrae
Publikováno v:
Blood advances. 6(4)
Cancer is associated with an increased risk of venous thromboembolism (VTE). In the CASSINI study, ambulatory cancer patients with a Khorana risk score ≥2 had a reduced risk of VTE while receiving rivaroxaban. This analysis used blood samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c045e3be65cb49c734fa9c836540e342
https://pubmed.ncbi.nlm.nih.gov/34807979
https://pubmed.ncbi.nlm.nih.gov/34807979
Autor:
Gemma Bendheim, Michael B. Streiff, Jodi V. Mones, Gerald A. Soff, Hanno Riess, Paul Burton, Alok A. Khorana, C.V. Damaraju, Peter Wildgoose
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Background Prophylactic anticoagulation with rivaroxaban significantly reduced the risk of cancer-associated thrombosis during the intervention period in the CASSINI trial. Direct oral anticoagulants may increase the risk of gastrointestinal (GI) tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df97b79cc7d9fb92834f6f08b97004e7
http://europepmc.org/articles/PMC8292144
http://europepmc.org/articles/PMC8292144
Publikováno v:
Blood Coagulation & Fibrinolysis. 27:899-906
Limited information exists regarding the relationship between international normalized ratio (INR) control/stability and the discontinuation of warfarin therapy among patients with nonvalvular atrial fibrillation (NVAF). This study evaluated the asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0cf3142db462a8afa23bff8756d7011
https://doi.org/10.1097/mbc.0000000000000515
https://doi.org/10.1097/mbc.0000000000000515
Autor:
C.V. Damaraju, Theodore Wun, Peter Wildgoose, Jai N. Patel, Ujjwala Vijapurkar, Keith R. McCrae, Nicole M. Kuderer, Gary H. Lyman, X. Zhou, Alok A. Khorana, S. Vadhan-Raj
Publikováno v:
Thrombosis Research. 200:S12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e3ce2fb220585f15f8ee76cf7778ad7
https://doi.org/10.1016/s0049-3848(21)00154-7
https://doi.org/10.1016/s0049-3848(21)00154-7
Autor:
Jaime Blais, Vlado Perkovic, C.V. Damaraju, Kent Y Feng, Jagadish Gogate, Jingwei Li, Kenneth W. Mahaffey, Michael A. Pfeifer, Meg Jardine, Bruce Neal
Publikováno v:
Metabolism. 116:154509
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b71c32f678f33abd9750bdfab3eac692
https://doi.org/10.1016/j.metabol.2020.154509
https://doi.org/10.1016/j.metabol.2020.154509
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xue Song, Winnie W. Nelson, C.V. Damaraju, Erin Thomson, Jeffrey Schein, David M. Smith, Craig I Coleman
Publikováno v:
Current Medical Research and Opinion. 31:1831-1840
To compare real-world persistence and discontinuation among non-valvular atrial fibrillation (NVAF) patients on rivaroxaban and dabigatran in the US.A large nationally representative US claims database was used to conduct a retrospective cohort analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b302d09e97c0c66076bdd1db092a643d
https://doi.org/10.1185/03007995.2015.1074064
https://doi.org/10.1185/03007995.2015.1074064